State Antitrust Enforcement Roundup: New Laws; New Potential Legislation; and New (and Broader) Areas of Focus

By:
(Sheppard Mullin)In this blog post, authors John Carroll, Jordan Grushkin, Jared Nagley, Malika Levarlet, and T.J. Benedict (Sheppard Mullin) provide an overview of the growing trend among U.S. states to adopt or expand antitrust laws, particularly focusing on transaction oversight. Many states continue to direct scrutiny toward the healthcare sector, as seen in New York’s proposed regulations requiring pre-closing filings for a wide range of health-related transactions. However, the scope of these developments is broadening, both in terms of industry and geography, with states like Arkansas, Texas, Utah, and West Virginia taking steps to significantly expand their antitrust frameworks.
A notable example is Arkansas’s newly enacted HB 1150, signed into law on April 16, 2025, which prohibits pharmacy benefit managers (PBMs) from owning pharmacies. Effective January 1, 2026, this first-of-its-kind legislation bars PBMs from holding direct or indirect interests in pharmacy retail operations. This move reflects a growing state-level push to address vertical integration concerns and potential conflicts of interest in the healthcare and pharmaceutical sectors.
Meanwhile, California is considering sweeping reforms to its antitrust laws following recommendations by the California Law Review Commission (CLRC). The CLRC suggests broad revisions to the Cartwright Act, including the creation of a standalone state merger control regime. Among its proposals is a reduced standard for challenging transactions, making it easier for the state to oppose deals independently of federal authorities. Additionally, Washington state has become the first to enact a general premerger notification law, applicable beyond specific sectors. Similar proposals are under review in several other jurisdictions, including Colorado, the District of Columbia, Hawaii, Nevada, Utah, and West Virginia…
Featured News
EU Regulators Probe SES-Intelsat Deal, Seek Insight on Starlink’s Competitive Threat
May 12, 2025 by
CPI
Trump Removes Copyright and Library of Congress Leaders After AI Policy Rift
May 12, 2025 by
CPI
Delta, Korean Air Buy Into WestJet in Major Cross-Border Deal
May 12, 2025 by
CPI
Trump Targets Big Pharma With Tough New Drug Pricing Rules
May 12, 2025 by
CPI
Geradin Partners Expands London Team with New Partner Hire
May 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece